论文部分内容阅读
对9例心力衰竭并发快速心房纤颤的患者静脉注射地尔硫(艹卓)(diltiazem),获得了迅速控制心室率而又不加重心衰的效果。全部病例均为首次到急诊室或心脏病加强护理病房就诊者。平均年龄68±9岁,病因分别为冠心病、高血压心脏病、甲亢所致心脏损害和急性二尖瓣关闭不全等。房颤的心室率≥120次/min,有心衰证据,如颈静脉压≥0.98kPa,两肺底布满湿性罗音,心尖部闻及第3心音奔马或有肺静脉淤血、心影扩大的X线表现。收缩压≤12kPa、PaO_2≤6 kPa,近6个月内发生过心肌梗塞、出血素质和24h内曾使用钙离子拮抗剂或β-受体阻滞剂者不在观察之列。
In nine patients with heart failure complicated by rapid atrial fibrillation, diltiazem was intravenously administered to achieve rapid ventricular rate control without worsening heart failure. All cases were for the first time to the emergency room or cardiology intensive care ward visits. The average age of 68 ± 9 years, the causes were coronary heart disease, hypertensive heart disease, hyperthyroidism caused by heart damage and acute mitral insufficiency. Ventricular rate of atrial fibrillation ≥ 120 times / min, there is evidence of heart failure, such as jugular venous pressure ≥ 0.98kPa, the bottom of both lungs full of wet rales, apex of the heart and the third heart beat or pulmonary venous congestion, heart shadow enlarged X-ray performance. Systolic blood pressure ≤ 12kPa, PaO_2 ≤ 6 kPa, myocardial infarction occurred in the past 6 months, hemorrhagic diathesis and 24h had used calcium antagonists or β-blockers were not observed.